| abstract |
The present invention relates to a method for preparing substituted 5-fluoro-1H-pyrazolopyridines. In particular, the present invention relates to novel and efficient processes for the preparation of novel substituted 5-fluoro-lH-pyrazolopyridines of formula (VI), which are suitable as intermediates for the preparation of Medicines and preparation of medicines for the treatment and/or prevention of cardiovascular diseases. More specifically, the 5-fluoro-1H-pyrazolopyridine compounds of formula (VI) are suitable for the preparation of compounds of formula (I), and the compounds of formula (I) are used for the preparation of medicines, for the preparation of treatment and/or prevention Cardiovascular disease drugs. |